ALVO News and Press, Alvotech

2026-03-12 20:35:00 ET The following segment was excerpted from the Royce Smaller-Companies Growth Fund FY 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Royce Smaller-Companies Growth Fund FY 2025: W...

REYKJAVIK, Iceland, March 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its fourth quarter and ...

2026-02-05 08:15:45 ET More on Alvotech, Takeda Pharmaceutical Takeda Tests New Highs, But Struggles To Find Entyvio Successor Takeda Pharmaceutical Company Limited (TAK) Q3 FY2025 Earnings Call Transcript Alvotech: Why FDA Delays Don't Break The Bull Case Al...

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio ® in healthy adult participants, met all its primary endpoints REYKJAVIK, Iceland, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology co...

REYKJAVIK, Iceland, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has entered into supply and commercialization agreements with Sando...

2026-01-29 03:25:39 ET Read the full article on Seeking Alpha For further details see: Alvotech resolves global patent disputes with Regeneron and Bayer over Eylea biosimilar

REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and...

2026-01-21 21:34:46 ET Since my October article , "My 5 Biggest Biotech Stocks Big Pharma Can Buy Now", Alvotech stock ( ALVO ) has fallen 44%, underperforming the S&P 500 [2.2% return] ( SPY ).... Read the full article on Seeking Alpha For further details se...

2026-01-06 08:46:46 ET More on Alvotech Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript Alvotech (ALVO) Q3 2025 Earnings Call Transcript Alvotech 2025 Q3 - Results - Earnings Call Presentation Alvotech ...

 - R ó bert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and m...